Management
from left to right: Volker Jenzelewski, Petra Zimmer, Michael Piontek, Melanie Piontek, Michael Weniger
Dipl.-Ing. Petra Zimmer (Finance Director)
Petra Zimmer is in charge of finances for ARTES. She is qualified as tax-advisor and runs her own business since more than 20 years, mainly with clients from the biotech branch. In between she has been full-time Chief Financial Officer of Rhein Biotech GmbH for five years. She holds a Master Degree in Machinery Construction and started her business experience with Arthur Andersen where she left as Manager.
P: +49 (0) 2173 27587 ‑22
E: p.zimmer(at)artes-biotechnology.com
Fine Art of Biotechnology
ARTES Biotechnology is a globally working, well established and reliable technology provider for recombinant protein production. We develop microbial cell lines and processes for vaccines, biopharmaceuticals, biosimilars and enzymes and offer ready-to-transfer processes for a wide range of products.
Our high experience team is available for tailor-made projects for the most efficient solution. We are experts in trouble-shooting and in the set-up of manufacturing processes.
All platform technologies (cell lines and vaccines) ensure freedom-to-operate and are protected by patents and trade secrets. ARTES is available to negotiate exclusive license terms.
WHO recommendation, international registrations, FDA approvals and GRAS certifications are part of the track record achieved in our international collaborations. Large-scale manufacturing and full analytics in accordance with cGMP guidelines are warranted in collaboration with partners.
Contact
ARTES Biotechnology GmbH
Elisabeth-Selbert-Str. 9
40764 Langenfeld
P: +49 (0) 2173 27587–0
F: +49 (0) 2173 27587–77
E: info (at) artes-biotechnology.com